#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Skin cancer Cystic fibrosis Loeys-Dietz syndrome Blastic plasmacytoid dendritic cell neoplasia KBG syndrome Autoimmune haemolytic anaemia Growth hormone deficiency Phenylketonuria Endometrial adenocarcinoma Acute graft versus host disease in liver Cold type haemolytic anaemia Epstein-Barr virus associated lymphoproliferative disorder Usher's syndrome Soft tissue sarcoma More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Diagnostics Basal cell naevus syndrome – Trials in Disease Skin angiosarcoma – Basic Information Primary hyperoxaluria – Life with Disease Haemolytic uraemic syndrome – Basic Information Hepatic angiosarcoma – Trials in Disease Hereditary neuropathic amyloidosis – Diagnostics Rhabdomyosarcoma – Trials in Disease Gaucher’s disease type I – Trials in Disease Factor VIII deficiency – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydrocortisone Acetate Imlifidase Lazertinib HEMOPEXIN, HUMAN Ecoo6A Tazemetostat Metreleptin GSKVX000000039711 Vibozilimod ULVIPRUBART Pivekimab Sunirine Oxytocin Cobolimab Misoprostol Soya Oil Albaconazole METHYLPHENIDATE Calcium Oxybate Phenylephrine Hydrochloride Mepivacaine Hydrochloride More therapies…

    Learn about Your Condition

    Systemic lupus erythematosus Non-small cell lung cancer Fungal infection Subdural haematoma Gestational diabetes Naevus flammeus Mitral valve incompetence Scoliosis Haemofiltration Metastases to biliary tract Malignant mast cell neoplasm Vascular malformation MELAS syndrome Major depression Endometrial cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Amoxicillin and Clavulanic Acid for Treating Ventilator-Associated Pneumonia in Intensive Care Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    France

  • Study on Reducing HIV Latent Reservoirs Using High Doses of Lamivudine, Maraviroc, and Dolutegravir Sodium for Patients with HIV Infection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir Sodium
    • Lamivudine
    • Maraviroc
    Spain

  • Study of Trastuzumab Deruxtecan for Patients with Early Stage HER2-Positive Breast Cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Paclitaxel
    • Pertuzumab
    Ireland

  • Study on Stopping Infliximab and Adalimumab Treatment in Patients with Crohn’s Disease and Ulcerative Colitis in Remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    • Infliximab
    Sweden

  • Study of personalized rituximab dosing using artificial intelligence in patients with membranous nephropathy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glomerulonephritis acute
    Investigated Drugs:
    • Rituximab
    France

  • Study on the Effect of Hydroxychloroquine for Patients with IgA Nephropathy and High Albumin Levels

    Recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    France
Previous Page
1 … 361 362 363 364 365 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!